{"transactions":[{"id":4616785,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":42484,"kind":"person","name":"Baker Daniel G.","position":1,"cik":"0002046802","reported_name":"Baker Daniel G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-09-14T20:03:07.000Z","date":"2026-09-10","kind":"grant","planned":false,"acquired":true,"shares":16250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in full on the earlier of September 10, 2027, or the date of the Issuer's 2027 annual stockholder meeting."}],"balance_after":16250,"derivative":{"exercise_price":10.42,"expiration_date":"2036-09-09","underlying":"Common Stock","underlying_shares":16250},"source":{"system":"sec-edgar","filing":"0001193125-26-390527","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2046802/000119312526390527/ownership.xml","form_type":"4"}},{"id":3573987,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":42484,"kind":"person","name":"Baker Daniel G.","position":1,"cik":"0002046802","reported_name":"Baker Daniel G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-09-08T21:55:56.000Z","date":"2026-09-08","kind":"grant","planned":false,"acquired":true,"shares":13750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in full on the earlier of September 8, 2027, or the date of the Issuer's 2027 annual stockholder meeting."}],"balance_after":13750,"derivative":{"exercise_price":10.88,"expiration_date":"2036-09-07","underlying":"Common Stock","underlying_shares":13750},"source":{"system":"sec-edgar","filing":"0001193125-26-385412","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2046802/000119312526385412/ownership.xml","form_type":"4"}},{"id":755334,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":42484,"kind":"person","name":"Baker Daniel G.","position":1,"cik":"0002046802","reported_name":"Baker Daniel G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:00:11.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":81000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents the right to purchase a total of 81,000 shares of the Issuer's common stock, which will vest in full on the earlier of the one-year anniversary of the grant date or immediately prior to the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":81000,"derivative":{"exercise_price":5.95,"expiration_date":"2036-05-29","underlying":"Common Stock","underlying_shares":81000},"source":{"system":"sec-edgar","filing":"0001193125-26-254127","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2046802/000119312526254127/ownership.xml","form_type":"4"}},{"id":810626,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":42484,"kind":"person","name":"Baker Daniel G.","position":1,"cik":"0002046802","reported_name":"Baker Daniel G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF DEVELOPMENT OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2026-04-10T20:00:03.000Z","date":"2026-04-09","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option becomes exercisable over four years, with 25% vesting on the one year anniversary of the grant date and the remainder vesting in equal, semi-annual installments thereafter."}],"balance_after":100000,"derivative":{"exercise_price":0.29,"expiration_date":"2036-04-08","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001193125-26-151200","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2046802/000119312526151200/ownership.xml","form_type":"4"}},{"id":988968,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":42484,"kind":"person","name":"Baker Daniel G.","position":1,"cik":"0002046802","reported_name":"Baker Daniel G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF DEVELOPMENT OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2025-11-25T21:00:04.000Z","date":"2025-09-29","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option becomes fully exercisable on the first anniversary of the grant date."}],"balance_after":50000,"derivative":{"exercise_price":0.72,"expiration_date":"2035-09-28","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001193125-25-296985","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2046802/000119312525296985/ownership.xml","form_type":"4"}},{"id":1051725,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":42484,"kind":"person","name":"Baker Daniel G.","position":1,"cik":"0002046802","reported_name":"Baker Daniel G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-02T10:35:03.000Z","date":"2025-08-28","kind":"grant","planned":false,"acquired":true,"shares":66300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents the right to purchase a total of 66,300 shares of the Issuer's common stock, and vests in three equal annual installments on each of the first three anniversaries of August 28, 2025, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":66300,"derivative":{"exercise_price":0.99,"expiration_date":"2035-08-28","underlying":"Common Stock","underlying_shares":66300},"source":{"system":"sec-edgar","filing":"0001193125-25-193327","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2046802/000119312525193327/ownership.xml","form_type":"4"}},{"id":1101200,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":42484,"kind":"person","name":"Baker Daniel G.","position":1,"cik":"0002046802","reported_name":"Baker Daniel G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-06-26T20:30:20.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":13750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in full on the earlier of  June 24, 2026, or the date of the Issuer's 2026 annual stockholder meeting."}],"balance_after":13750,"derivative":{"exercise_price":1.61,"expiration_date":"2035-06-23","underlying":"Common Stock","underlying_shares":13750},"source":{"system":"sec-edgar","filing":"0001415889-25-018278","document":"form4-06262025_040608.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2046802/000141588925018278/form4-06262025_040608.xml","form_type":"4"}},{"id":1192473,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":42484,"kind":"person","name":"Baker Daniel G.","position":1,"cik":"0002046802","reported_name":"Baker Daniel G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF DEVELOPMENT OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2025-03-25T20:00:07.000Z","date":"2025-03-21","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option becomes exercisable in eight equal semi-annual installments beginning on September 21, 2025."}],"balance_after":100000,"derivative":{"exercise_price":0.99,"expiration_date":"2035-03-20","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000950170-25-044346","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2046802/000095017025044346/ownership.xml","form_type":"4"}},{"id":1292047,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":42484,"kind":"person","name":"Baker Daniel G.","position":1,"cik":"0002046802","reported_name":"Baker Daniel G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-01-29T21:33:38.000Z","date":"2025-01-28","kind":"grant","planned":false,"acquired":true,"shares":27500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the shares vested following the grant date, with the remaining shares vesting monthly over an additional two years following January 28, 2025,"}],"balance_after":27500,"derivative":{"exercise_price":5.56,"expiration_date":"2035-01-27","underlying":"Common Stock","underlying_shares":27500},"source":{"system":"sec-edgar","filing":"0001415889-25-002273","document":"form4-01292025_090134.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2046802/000141588925002273/form4-01292025_090134.xml","form_type":"4"}},{"id":1348529,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":42484,"kind":"person","name":"Baker Daniel G.","position":1,"cik":"0002046802","reported_name":"Baker Daniel G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF DEVELOPMENT OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2024-11-29T21:00:05.000Z","date":"2024-11-25","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an inducement stock option granted on November 25, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option will become exercisable over two years in equal, semi-annual installments beginning on May 25, 2025."}],"balance_after":200000,"derivative":{"exercise_price":1.06,"expiration_date":"2034-11-24","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0000950170-24-131890","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2046802/000095017024131890/ownership.xml","form_type":"4"}}]}